Overview

A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the gastroduodenal ulceration rate, gastrointestinal complication rate and non-steroidal anti-inflammatory drug-associated dyspepsia between lansoprazole, naproxen and celecoxib, taken once daily (QD) or twice daily (BID), in participants with osteoarthritis taking low dose aspirin.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Aspirin
Celecoxib
Dexlansoprazole
Lansoprazole
Naproxen